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ABSTRACT
Int J Exerc Sci 5(1) : 26-38, 2012. The present study was designed to examine the relationship
between homocyst(e)ine (H[e]) levels and muscle mass. Two experimental groups each of 24
Caucasian males, one consisting of higher-muscle mass subjects (HMM) and the other of lowermuscle mass subjects (LMM) par-ticipated in this study. Muscle mass was estimated from 24hour urine collections of creatinine (Crt). Muscle mass was 40.3 ± 15.9 kg in HMM and 37.2 ± 11.4
kg in LMM (P= 0.002). Mean plasma H(e) levels in HMM were 10.29 ± 2.9 nmol/mL, and in LMM
were 10.02 ± 2.4 nmol/L (Not significant, [NS]). Urinary H(e) levels (UH[e]) were 9.95 ± 4.3
nmol/mL and 9.22 ± 2.9 nmol/mL for HMM and LMM, respectively (NS). Plasma H(e) levels
correlated well with UH(e) (HMM: r= 0.58, P= 0.009; LMM: r= 0.66, P= 0.004). Muscle mass and
was not correlated to either plasma H(e) or UH(e). However, in HMM trends were identified for
body mass to be cor-related with UH(e) (r= 0.39, P= 0.10) and UCrt (r= 0.41, P= 0.08).
Surprisingly, in HMM plasma and UCrt were only weakly correlated (r= 0.44, P= 0.06). Our
results do not support a causal relationship between the amount of muscle mass and H(e) levels
in plasma or urine.

KEY WORDS: Creatinine, homocysteine, estrogen, gender-differences, skeletal
muscle

INTRODUCTION
Today,
atherosclerotic
cardiovascular
disease (CVD) is representing a leading
cause of mortality in the United States (37)
and many European countries (33). The risk
factors are broadly the same for both
genders: cigarette smoking, inactivity, high
LDL cholesterol levels, hypertension, and

diabetes (33, 37, 43, 48). One predictor of
CVD that has received much attention since
the 1990s is homocyst(e)ine (8, 42, 47).
Homocyst(e)ine is an amino acid that is
produced during the conversion of dietary
protein into energy, a process which seems
to damage the arteries (25, 40, 44).
Homocyst(e)ine levels are higher in males
than in females, and it has been speculated

HOMOCYST(E)INE AND MUSCLE MASS
that this might contribute to the overall
higher incidence of CVD in men, when
compared to women (3, 25, 26). Exactly
why this gender-specific difference in
homocyst(e)ine concentrations exists has
long been the subject of considerable
debate.

to date, to the best of our knowledge, no
study has attempted to assess muscle mass
effects on homocysteine levels in same-sex
groups in order to exclude this major
confounder represented by an estrogen- vs.
a testosterone-rich environment. Thus, it is
the purpose of the present study to
investigate the possible role of muscle mass
on plasma and urine homocyst(e)ine and
creatinine levels in same-gender subjects
(males). Our hypothesis is that differences
in H(e) levels might be attributed to
differences in muscle mass. In addition, we
also wanted to see if muscle mass might
affect the clearance of H(e).

Brattström et al. (6) have hypothesized that
such sex-differences could be attributable to
muscle
mass.
It
is
known
that
approximately 98% of creatinine is derived
from creatine formed in the muscle, and
that the amount of creatinine released is
determined by muscle mass (38). The
formation of creatine (from which
creatinine proceeds) depends on the methyl
donation by S-adenosylmethionine, a
process which leads to the formation of
homocysteine (2, 40). Mudd and Poole (32)
and Brattström et al. (6), consequently, were
able to demonstrate positive correlations
between levels of homocyst(e)ine and
plasma creatinine. These findings led these
authors to opine that the homocysteine
concentration too would be expected to
reflect muscle mass as much as the
creatinine
concentration
does,
and
speculated that this might be the reason
why men will generally have higher
concentrations of both creatinine and
homocysteine (3, 13).

METHODS
Participants
All procedures of this study were
conducted in compliance with institutional
ethics
procedures
and
expectations
described in the Declaration of Helsinki.
Following institutional ethics approval,
subjects provided informed consent after
the purpose and content of the experiments
were carefully explained. Two different
subject groups each consisting of 24
Caucasian males, between 18-45 years,
volunteered to participate in this study.
Based upon effect sizes calculated from
meta-analysis of other studies that have
measured homocyst(e)ine in subjects of
similar ages (26, 36, 42), the minimal
required sample size in each group in order
to maintain a statistical power of 0.8, was
determined as 23. Subjects were assigned to
either the higher (HMM) or the lower
muscle mass group (LMM) based on the
consideration that those subjects regularly
engaging in weightlifting and resistance
training would likely have more muscle
mass than those only engaging in aerobic

However, the actual relationship between
homocysteine and muscle mass itself has
not been investigated sufficiently. The few
studies that have looked into the
relationship between both, have compared
males and females hence having been
confounded by many important factors
such as particularly sex steroids and
menstrual cycle fluctuations (10, 13). It
therefore remains somewhat surprising that
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running. To avoid subjects with more
muscle mass being also heavier and
therefore introducing an overall higher
body mass as a confounder, we elected that
subjects should be matched for body mass.
HMM subjects engaged in weightlifting for
at least 4 days per week for more than a
year, whilst not engaging in regular aerobic
exercise. Subjects in this experimental
group all were members of a police riot
squad,
whose
professional
training
included regular weightlifting. Inclusion
criteria for the second experimental group,
which consisted exclusively of LMM
subjects, required being involved in regular
(at least 4 times per week) aerobic training
and not lifting weights. LMM subjects were
selected from the local community. Levels
of physical activity of the subjects were
obtained through interview questions but
not experimentally verified.

hypercholesterolemia, or diabetes were
excluded from the study.
Experimental design
The study consisted of a single trial during
which data were collected on the subjects'
body composition to allow calculation of
muscle mass, and to correlate these values
with H(e) concentrations in plasma and
urine.
HMM
subjects
were
given
instructions on how to collect 24h-urine,
and they were provided with 5-liter
containers during a subject group meeting
at their Bedford Police Station; LMM
subjects were provided with the same
during individual meetings prior to
scheduling their experimental lab visits.
Subjects were also reminded to refrain from
taking vitamin B, folate, protein or creatine
monohydrate dietary supplements, and
were told to stay sufficiently hydrated
when completing 24-hour urine collections
and before reporting to the lab for
bioimpedance
body
composition
measurements. After having explained
instructions and addressed eventual
questions, subjects were told to schedule a
visit to the lab facility between 10-12 am,
during which they provided a fasting single
venous blood sample. At that occasion they
also delivered their containers with 24-hour
urine collections. Subjects had been
instructed to not exercise prior to blood,
urine and bioimpedance body composition
data collection. Exclusion criteria were:
having taken dietary supplements, illness,
or showing signs of dehydration, such as,
for example, 24-hour urine collections
<1,000 mL or containing <400 mg
creatinine, as recommended by Flegg &
Lakatta (11).

None of the subjects in either group, as far
as known, suffered from any disease that
might interfere with H(e) metabolism.
Subjects were not controlled for caloric
intake, but the following restrictions on
dietary supplements were enforced. In
particular, subjects were not allowed to
take (or have taken within the previous two
months) any vitamin B or folate
supplements (these lower H(e) levels), or
protein
or
creatine
monohydrate
supplements (these would interfere with
and artificially increase urine creatinine
concentrations). Relevant personal details
(anamnesis, training history) were collected
using a questionnaire which the subjects
completed in the presence of an exercise
physiologist
familiar
with
the
questionnaire's
contents
and
aims.
Individuals with a family history of CVD,
or who had self-reported hypertension,
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Anthropometrical measurements
For both groups height, body mass, and age
were recorded. In addition, body
composition was measured using a bioelectrical impedance analyzer (Biostat 1500,
Bodystat Ltd., Douglas Isle of Man, British
Isles). This method sends a minimal current
through the body and measures its
impedance. Recommendations to subjects
before and during bioimpedance analysis
included abstinence from caffeine and
remaining sufficiently hydrated.
Lean
body mass (LBM) was calculated by
subtracting fat tissue mass from total body
mass. Muscle mass was estimated from
creatinine excretion as described later in
this paper.

previously described in detail (27). The
within-assay coefficient of variation (cvi) of
the method described above was 2.0% and
the between-assay coefficient of variation
(cvb) below 7.0%.
Plasma samples were also analyzed for
creatinine.
Therefore
we
used
a
commercially available kit from Sigma (St.
Louis, MO) for quantitative colorimetric
analysis. This method was based on the
color change that occurs when alkaline
picrate is exposed to creatinine (Jaffé
reaction) (5).
Urine collection and analysis
Subjects provided 24-hour samples of urine
for analysis of urinary homocyst(e)ine
(UH[e]) and creatinine (UCrt). Urine was
collected in previously distributed 5-L
plastic containers (Richardsons, Leicester,
UK or similar), which were kept
refrigerated during use. The container was
then transported to the lab, the urine
volume (UVol) recorded, mixed and two
30-mL aliquots frozen and stored at -80 °C
until analysis. UH(e) and UCrt were
measured in 30 mL aliquots according to
methods similar to those described above
for plasma concentrations.

Blood collection and analysis
Subjects had to provide a single 10-mL
sample of venous blood obtained from an
antecubital vein using a disposable syringe.
The sample was immediately transferred to
pre-cooled
5-mL
di-potassium
ethylenediamine
tetra-acetate
(EDTA)
polypropylene tubes. These tubes were
then centrifuged for 5 minutes at 3,000 g.
The plasma was pipetted into 1.5 mL
Eppendorf cups and immediately frozen at
-80°C until analysis.
Blood samples were analyzed for plasma
total homocyst(e)ine (H[e]), which is the
sum
of
homocysteine
and
the
homocysteinyl moieties of the disulfides
homocystine and cysteine-homocysteine,
whether free or bound to proteins (25, 26,
44). All H(e) analyses were performed at, or
according to procedures identical to those
established by Malinow et al. (27). This is
an automated method based on highpressure liquid chromatography (HPLC)
with
electrochemical
detection,
as
International Journal of Exercise Science

UCrt excretion was used to predict muscle
mass. The 24-hour creatinine excretion is an
easily measurable and validated index of
total muscle mass (38, 46). Because it has
been demonstrated that per 18.5 kg of
muscle, one gram of creatinine is excreted
(7, 17), muscle mass can be estimated by the
formula:
Muscle mass in kg= 1.85 × mg creatinine
excreted per day: body mass
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Despite prior validation of estimating body
mass on urinary creatinine excretion (11, 12,
17, 38, 46), one limitation is that creatinine
will also be derived from ingested muscle
such as red meat, which means that ideally
a meat-free diet for approximately 3 days
prior to the testing should be required.
However, because our estimations used 24hour samples of urine the possible effect of
meals is attenuated (18). Therefore, we
chose not to apply the fasting method.

The clearance rates of creatinine (CRCrt) and
homocyst(e)ine (CRHe) were computed
according to the knowledge that the
excretion of a substance equals the urinary
excretion of the substance divided by the
plasma concentration of the substance (39):
CRCrt =
EXRCrt × Crt-1 = (UCrt ×
-1
UVol) × Crt
CRHe = EXRHe × H(e)-1 = (UH(e) × UVol) ×
H(e)-1

Calculation of renal clearance
Because we measured H(e) and creatinine
in both plasma and urine, it allows us to
calculate clearance rates and renal function
(39). The excretion rate of creatinine
(EXRCrt) and homocyst(e)ine (EXRHe) were
estimated as follows:

This, then also allows estimation of tubular
resorption of creatinine (TRESCrt) and
homocyst(e)ine (TRESHe) (39):
TRESCrt = (CRCrt × Crt) - (UCrt × UVol)
TRESHe = (CRHe × He) - (UHe × UVol)

EXRCrt=

UCrt × UVol

EXRHe=

UH(e) × UVol

Statistical analysis
Normal probability plot showed that date
sets were normally distributed. Student's

Table 1: Anthropometrical characteristics of the participants (high-muscle mass subjects vs. low-muscle
mass subjects). Values represent means ± SD (N= 24, in each group).

Variable

High-Muscle Mass

Low-Muscle Mass

P-

Group

Group

value

Age (yr)

32.4 ± 2.5

31.8 ± 2.4

NS

Height (cm)

181.1 ± 2.6

186.2 ± 4.2

0.01

Body mass (kg)

86.2 ± 11.0

85.7 ± 9.8

NS

Body fat (%)

17.2 ± 4.0

14.8 ± 2.6

0.03

Lean body mass (kg)

72.1 ± 2.9

73.1 ± 3.5

NS

Muscle mass (kg)

40.3 ± 15.9

37.2 ± 11.4

0.02

BMI

26.7 ± 2.8

24.6 ± 2.6

0.03

International Journal of Exercise Science

30

http://www.intjexersci.com

HOMOCYST(E)INE AND MUSCLE MASS
two-sample t-test was anticipated to be
appropriate. The t-test remains robust even
with moderate departures from normality.
In a recently completed study using similar
outcome variables, the distribution of the
levels of H(e) showed no radical departures
from normality. If the dispersion of the data
was strongly related to the mean, the t-test
was applied to the log-transformed data.
The Bonferroni correction (dividing alpha
by the number of comparisons) was
considered but rejected for a number of
reasons, such as groups compared not
being identical on all variables and because
of a reluctance to inflate type II errors in
order to decrease type I errors. To support
the conclusions based on the t-test, the
corresponding rank tests were also carried
out.

17.2 ± 4.0% and their muscle mass 40.3 ±
15.9 kg, whereas the LMM group had a
mean BMI of 24.6 ± 2.6 (P=0.03), body fat
percentage of 14.8 ± 2.6 (P= 0.03), and a
muscle mass of 37.2 ± 11.4 kg (P= 0.02).

Homocyst(e)ine (nmol/mL)

Homocyst(e)ine and creatinine values
Mean plasma homocyst(e)ine levels were
10.29 ± 2.9 nmol/mL in HMM and 10.02 ±
2.4 nmol/mL in LMM (NS) (standard
laboratory values: 5-15.9 nmol/mL) (Figure
1). However, one HMM subject had
elevated values at 16.90 nmol/mL. Urinary
H(e) values averaged 9.95 ± 4.3 nmol/mL
for HMM and 9.22 ± 2.9 nmol/mL for LMM
(NS), respectively.

Pearson's correlation coefficient was used
to assess the relationship between H(e) and
indicators of muscle mass, being lean body
mass and creatinine concentrations,
respectively. The α-level was set a priori at
0.05. Data analysis was completed using the
Statistical Package for the Social Sciences,
versions 13-17 for MS-Windows (SPSS Inc.,
Chicago, IL). Results are presented as
means ± SD.

10

5
Plasma H(e)

Urine H(e)

Figure 1. Plasma and urine homocyst(e)ine levels in
high-muscle mass (white bars) vs. low-muscle mass
(black bars) males. Values are means ± SD.
*Significantly different P<0.05.

RESULTS
Body composition and estimation of muscle
mass
Twenty-four male subjects in each group
successfully completed this trial. Their
descriptive values are mentioned in Table 1.
Mean body mass was 86.2 ± 11.0 kg in
HMM subjects and 85.7 ± 9.8 kg in LMM
subjects (not significant, [NS]). Although
the HMM subjects had a mean BMI of 26.7
± 2.8 their mean percentage of body fat was

International Journal of Exercise Science
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Creatinine concentrations in plasma were
for HMM: 1.3 ± 0.2 mg/dL and for LMM:
1.2 ± 0.2 mg/dL (NS; normal: 0.9-1.4
mg/dL),
and
urinary
creatinine
concentrations expressed per metric unit
were 124.8 ± 49.7 mg/dL for HMM and
103.1 ± 32.4 mg/dL (P= 0.03) for LMM;
Total UCrt excretion per day for LMM was
2,264 ± 542 mg/d and 1,729 ± 334 mg/d for
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HMM (normal: 1,100-2,800 mg/d) (Figure
2).

urine H(e) levels in both subject groups
(HMM: r= 0.44, P= 0.03; LMM: r= 0.54, P=
0.01). Plasma creatinine in HMM, however,
did not significantly correlate with urinary
creatinine. No significant correlations were
found between plasma H(e) and creatinine
in either group, whereas the urinary
equivalents of both parameters were
significantly correlated (HMM: r= 0.64, P=
0.001; LMM: r= 0.67, P= 0.001). Plasma H(e)
levels in either group were not significantly
correlated with BMI (HMM: r= 0.50; LMM:
r= 0.38), body mass (HMM: r= 0.35; LMM:
r= 0.29), muscle (HMM: r= 0.02; LMM: r=
0.34) or body fat (HMM: r= 0.26; LMM: r=
0.28). Both urinary H(e) and creatinine
levels showed trends towards weak
correlations with body mass (r= 0.39, P=
0.10 & r= 0.41, P= 0.08, respectively), but
only in the HMM subjects.

180

Creatinine (mg/dL)

160

*

140
120
100
80
60
40
20
0
-20
Plasma Crt

Urinary Crt

Figure 2. Plasma and urine creatinine levels in
weight-trained or high-muscle mass (white bars) vs.
low-muscle mass (black bars) males. Values are
means ± SD. *Significantly different P<0.05.

Correlations
between
homocyst(e)ine,
creatinine, and body composition
Plasma H(e) correlated moderately with

Table 2: Overview of the contribution of renal function to H(e) and creatinine concentrations in highmuscle mass subjects vs. low-muscle mass subjects. Values represent means ± SD (N= 24, in each group).

Parameter

High-Muscle Mass

Low-Muscle Mass

P-value

Group

Group

Homocyst(e)ine (μmol/d)

18.1 ± 4.7

15.6 ± 3.1

NS

Creatinine (g/d)

2.3 ± 0.5

1.7 ± 0.3*

0.03

1.2 ± 1.1

1.1 ± 0.8

NS

120.9 ± 21.7

100.1 ± 16.2

NS

<0.1

<0.1

NS

1.4 ± 0.3

1.1 ± 0.2

NS

Excretion Volume

Clearance Rate
Homocyst(e)ine (mL/min)
Creatinine (mL/min)
Tubular Reabsorption
Homocyst(e)ine (nmol/min)
Creatinine (mg/min)
*Significantly different LMM vs. LMM
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Renal clearance and tubular resorption
Data of renal function are summarized in
Table 2. The mean EXRCrt was 2.3 ± 0.5 g/d
or 26.3 ± 5.0 mg · kg-1 · day-1 in HMM and
1.7 ± 0.3 g/d or 20.2 ± 3.4 mg · kg-1 · day-1 in
LMM (P= 0.03). CRCrt values were 120.9 ±
21.7 mL/min and 100.1 ± 16.2 mL/min in
HMM and LMM, respectively (NS), which
was within normal laboratory ranges (90135 mL/min). The mean EXRH(e) and CRH(e)
values were 18.1 ± 4.7 μmol/d and 1.2 ± 1.1
mL/min, respectively in HMM, and 15.6 ±
3.1 μmol/d and 1.1 ± 0.8 mL/min,
respectively in LMM (NS). No significant
group differences for TRESHe values were
found.

Our initial hypothesis was that differences
in H(e) levels might be attributed to
differences in muscle mass. In this study,
muscle mass was estimated based on
urinary creatinine excretion. The total daily
volume of excreted creatinine in urine was
higher in the HMM than in the LMM,
which is in line with expectations. Our
further findings, in particular our
observation of H(e) in either plasma or
urine not being significantly correlated with
muscle mass, body mass, or percentage of
body fat, does not lend support to our
hypothesis. It is therefore highly unlikely
that muscle mass would represent an
important factor in determining H(e) levels.

DISCUSSION

Renal clearance is the volume of blood that
is cleared of a particular substance per unit
of time (39). It provides an approximation
of glomerular filtration rate (GFR) and of
renal function. GFR can theoretically be
estimated in measuring the clearance of any
chemical substance on the condition that it
has a stable level in blood, and that it is
freely filtered but not reabsorbed or
secreted
by
the
kidney.
Tubular
reabsorption then is the process by which
solutes and water are removed from
tubular fluid and transported back into the
blood (39). In the present study, data for
renal clearance rates and tubular resorption
of both creatinine and H(e) were within
normal ranges. The absence of any
significant differences for these parameters
between the two subject groups suggests
that our subjects had a clinically normal
renal function, and that differences in
muscle mass do not affect clearance of
either H(e) or creatinine. We also note that
our data suggest that tubular resorption of
H(e) is almost nonexistent. This finding is
in agreement with Arnadottir & Hultberg

With the exception of two HMM
individuals
who
showed
moderate
hyperhomocyst(e)inemia' (between 16-30
nmol/mL), all subjects had mean H(e)
values which were within normal ranges
and well in agreement with typical
concentrations in healthy males reported by
other researchers (6, 26, 43).
H(e) is traditionally determined in plasma,
but can also be measured in urine. This is
not generally performed because of the
difficulties
with
obtaining
24-hour
collections of urine. In the present study we
found that urinary H(e) concentrations
correlated well with those in plasma. This
finding is in agreement with existing
literature. For example, Brattström et al. (6)
found significant correlations between
urine and plasma H(e) correlations of r=
0.51 in athero-thrombotic patients and r=
0.42 in controls (both, P<0.001), which is
similar to what we found.
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(2) and with Wollesen et al. (49), who
concluded that H(e) is ultrafiltrated in
glomeruli, almost completely absorbed in
tubuli, and degraded in kidney tissue by
transmethylation and transsulfuration, and
that healthy humans typically return as
much H(e) to the circulation as is
ultrafiltrated in glomeruli.

salvaged by acquisition of a methyl group
from N5-methyl-tetrahydrofolate in a
vitamin B-12–dependent pathway or from
betaine. Using ANCOVA, these authors
adjusted remethylation for fat-free mass
and muscle mass, respectively, and noted
that only adjustment for fat-free mass
attenuated gender-differences in H(e). In
other words, fat-free mass, but not muscle
mass, appeared to affect remethylation.
Thus, similar to us, their findings too were
unable to confirm the amount of muscle
mass as a critical determinant in mediating
H(e) levels as had been suggested
previously (2, 6, 10, 32).

It has been suggested before that 75% of
H(e) production takes place in direct
conjunction with the formation of creatine
and creatinine (1, 32), but literature data are
inconsistent. Some authors have found
positive correlations between plasma
creatinine and H(e) in patients with CHD
and stroke (6, 20, 24), while others have not
(49). Brattström and colleagues (6) have
previously demonstrated that only in male
and female patients with CVD they were
able to perceive such a correlation between
plasma creatinine and H(e), but not in their
healthy control subgroups. If muscle mass
would have been a major mediating factor
of H(e), one would expect to find such a
correlation in healthy subjects too.

Another consideration that is hard to join
with the muscle mass/homocysteine
hypothesis is that muscle mass typically
decreases with advancing age, whereas
homocysteine levels tend to increase.
Certainly, there are other confounders
involved in the process of aging, but it
nevertheless adds even more arguments
against than in support of the muscle masshomocysteine hypothesis.

With the exception of anthropometric
differences (mostly as a consequence of
subjects being selected into either HMM or
LMM groups), total creatinine excretion
and urinary creatinine levels, no significant
differences were found in metabolic
parameters between the HMM and LMM
subject groups. The absence of differences
in H(e) as far as related to muscle mass
seems to support the conclusions of
Fukagawa et al. (13), and is also in
agreement with Mora and colleagues (30).
Fukagawa et al. (13) investigated the effect
of remethylation of homocysteine in the
liver in determining H(e) levels. During the
process of remethylation homocysteine is
International Journal of Exercise Science

Because neither we, nor Fukagawa et al.
(13), nor Mora et al. (30) have been able to
confirm a muscle mass/homocysteine
relationship, and since we were not even
able to find a significant correlation
between creatinine and H(e) in every
subject, other explanations should be
considered. Creatinine also represents an
index of renal function, and its circulating
levels and metabolism are influenced by
renal and liver disease (12, 34). Potentially,
it may be or may have been kidney function
rather than muscle mass which was
reflected in the relationship creatinine/H(e)
which Brattström and colleagues (6)
observed in patients with CVD. Based on
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increased
H(e)
levels
found
in
haemodialysis patients and chronic kidney
disease patients (19, 23), it has, indeed, been
argued that H(e) levels would depend on
the level of renal function (23, 24, 26).

Absorptiometry (DEXA) (22), have become
the method of choice for estimating muscle
mass. However, this was not yet so at the
time we commenced the present study,
which took much longer to complete than
expected due the difficulties in recruiting a
sufficient number of LMM subjects weightmatched for all HMM subjects. One reason
for these difficulties was that aerobic
athletes on the average are lighter than
athletes or subjects who only engage in
weight-training making it difficult to
weight-match subjects from both groups.

Since muscle mass, contrary to our starting
hypothesis, does not appear to be a
determinant in H(e) levels in same-gender
subjects, it is unlikely it would be in
causing male vs. female differences in H(e)
levels. The results from Fukagawa et al. (13)
obtained in male vs. female subjects lend
credence to this assumption. The most
obvious confounder to present a challenge
to the muscle/H(e) hypothesis when
comparing homocysteine levels across
gender, clearly are the major differences in
sex steroid hormones (29). An abundant
number of studies has now been able to
demonstrate that H(e) concentrations are
negatively correlated with estradiol levels
(4, 9, 31, 41, 45, 50). Moreover, H(e) levels
significantly decrease following four
months of treatment with ethinyl estradiol
and the anti-androgen cyproterone acetate
in the male-to-female transsexuals, whereas
they significantly went up in the female-tomale transsexuals H(e) levels after two
weeks of treatment with testosterone (16).
Sex steroids may also play a role in samegender differences in H(e) levels related to
different types of physical activity. For
example, animal experiments have shown
that testosterone significantly alters the
formation
and
utilization
of
Sadenosylmethionine, a key factor in the
synthesis of H(e) (28).

In the present study we did not make use of
a methionine-loading test (1) mainly
because of evidence suggesting that this
method in people with the so-called
'thermolabile' alternative form of one of the
converting
enzymes
(N5,N10methylenetetrahydrofolate reductase might
lead to considerable errors (15). The authors
are
aware
of
potential
additional
confounders, such as age, temperature, pH
(low pH causes increased formation of
creatinine), and an approximately 15%
daily
intra-individual
variation
in
creatinine excretion (14, 21, 35). In addition,
inter-individual differences in H(e) levels
may be caused by the rate of remethylation
in the liver. In remethylation, homocysteine
is salvaged by acquisition of a methyl
group from N5-methyl-tetrahydrofolate in
a vitamin B-12–dependent pathway or from
betaine. Other limitations are that, if one
individual at the same time has a 20%
higher creatinine production rate and
clearance rate when compared to another
individual, the creatinine levels of both
individuals may very well be similar
though they may reflect a thoroughly
different muscle mass.

The authors recognize that today other
perhaps more reliable techniques, such as
notably CAT-scan, Magnetic Resonance
Imaging (MRI), or Dual X-ray-Energy
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The results obtained from the present study
suggest that: (a) our data do not support the
existence of a causal relationship between
the amount of muscle mass and H(e) levels
in plasma or urine in healthy male
volunteers; (b) plasma and urinary H(e)
levels correlate well.

5. Bonsnes RW, Taussky HH. On the colorimetric
determination of creatinine by Jaffé reaction. J Biol
Chem 581: 158-163, 1945.
6. Brattström L, Lindgren A, Israelsson B.
Hyperhomocysteinaemia in stroke: prevalence,
cause, and relationships to type of stroke and stroke
factors. Eur J Clin Invest 22: 214-221, 1992.
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